Nature Communications (Oct 2018)

Coordinated targeting of cold and nicotinic receptors synergistically improves obesity and type 2 diabetes

  • Christoffer Clemmensen,
  • Sigrid Jall,
  • Maximilian Kleinert,
  • Carmelo Quarta,
  • Tim Gruber,
  • Josefine Reber,
  • Stephan Sachs,
  • Katrin Fischer,
  • Annette Feuchtinger,
  • Angelos Karlas,
  • Stephanie E. Simonds,
  • Gerald Grandl,
  • Daniela Loher,
  • Eva Sanchez-Quant,
  • Susanne Keipert,
  • Martin Jastroch,
  • Susanna M. Hofmann,
  • Emmani B. M. Nascimento,
  • Patrick Schrauwen,
  • Vasilis Ntziachristos,
  • Michael A. Cowley,
  • Brian Finan,
  • Timo D. Müller,
  • Matthias H. Tschöp

DOI
https://doi.org/10.1038/s41467-018-06769-y
Journal volume & issue
Vol. 9, no. 1
pp. 1 – 13

Abstract

Read online

Tobacco smoking and cold exposure are environmental modulators of human energy metabolism suppressing appetite and increasing energy expenditure, respectively. Here, the authors develop a novel pharmacological strategy in which they simultaneously mimic the metabolic benefits of both phenomena through small-molecule combination therapy, and show that this treatment improves metabolic health of obese mice.